Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, 7SL, cytoplasmic 168, pseudogene (RN7SL168P)** is classified as a pseudogene in the human genome[1][5][8]. Pseudogenes are nonfunctional segments of DNA that resemble functional genes but typically do not produce functional proteins or RNA products[2]. Specifically, RN7SL168P is one of hundreds of dispersed 7SL RNA-like sequences in the human genome and does not encode a functional product; the functional counterpart, 7SL RNA, is a component of the signal recognition particle (SRP), essential for co-translational targeting of proteins to the endoplasmic reticulum[4][7][9]. However, as a pseudogene, RN7SL168P has lost this function and is not involved in any known signaling or disease pathway, nor is it a therapeutic target or biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 168, pseudogene (RN7SL168P).